Misplaced Pages

Etiracetam: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 09:45, 22 March 2020 editBoghog (talk | contribs)Autopatrolled, Extended confirmed users, IP block exemptions, New page reviewers, Pending changes reviewers, Rollbackers, Template editors137,879 edits consistent citation formatting← Previous edit Latest revision as of 00:26, 23 January 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers173,826 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox {{Drugbox
| Verifiedfields = changed | Verifiedfields = changed
Line 32: Line 33:
<!-- Chemical data --> <!-- Chemical data -->
| C=8 | H=14 | N=2 | O=2 | C=8 | H=14 | N=2 | O=2
| molecular_weight = 170.209 g/mol
| smiles = CCC(C(=O)N)N1CCCC1=O | smiles = CCC(C(=O)N)N1CCCC1=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
Line 39: Line 39:
| StdInChIKey = HPHUVLMMVZITSG-UHFFFAOYSA-N | StdInChIKey = HPHUVLMMVZITSG-UHFFFAOYSA-N
}} }}
'''Etiracetam''' is a chemical compound belonging to the ] family, which was developed as a ] drug. It is ]; its biologically active ]ic form is ], now marketed as an ].<ref>{{cite journal | vauthors = Sara SJ | title = Memory retrieval deficits: alleviation by etiracetam, a nootropic drug | journal = Psychopharmacology | volume = 68 | issue = 3 | pages = 235–41 | year = 1980 | pmid = 6771807 | doi = 10.1007/bf00428109 }}</ref> '''Etiracetam''' is a chemical compound belonging to the ] family, which was developed as a ] drug. It is ]; its biologically active ]ic form is ], now marketed as an ].<ref>{{cite journal | vauthors = Sara SJ | title = Memory retrieval deficits: alleviation by etiracetam, a nootropic drug | journal = Psychopharmacology | volume = 68 | issue = 3 | pages = 235–41 | year = 1980 | pmid = 6771807 | doi = 10.1007/bf00428109 | s2cid = 23369972 }}</ref>


== See also == == See also ==

Latest revision as of 00:26, 23 January 2023

Chemical compound Pharmaceutical compound
Etiracetam
Clinical data
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • US: Unscheduled
Identifiers
IUPAC name
  • (RS)-2-(2-Oxopyrrolidin-1-yl)butanamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.111.445 Edit this at Wikidata
Chemical and physical data
FormulaC8H14N2O2
Molar mass170.212 g·mol
3D model (JSmol)
ChiralityRacemic mixture
SMILES
  • CCC(C(=O)N)N1CCCC1=O
InChI
  • InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)
  • Key:HPHUVLMMVZITSG-UHFFFAOYSA-N
  (what is this?)  (verify)

Etiracetam is a chemical compound belonging to the racetam family, which was developed as a nootropic drug. It is racemic; its biologically active enantiomeric form is levetiracetam, now marketed as an antiepileptic drug.

See also

References

  1. Sara SJ (1980). "Memory retrieval deficits: alleviation by etiracetam, a nootropic drug". Psychopharmacology. 68 (3): 235–41. doi:10.1007/bf00428109. PMID 6771807. S2CID 23369972.
Racetams
Racetams
Phenylpiracetams
Racetam-like
Stub icon

This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it.

Categories:
Etiracetam: Difference between revisions Add topic